首页 › 自身免疫性疾病 › 宾夕法尼亚州 › Philadelphia
Philadelphia PA 自身免疫性疾病临床试验
16项针对 自身免疫性疾病的研究正在 Philadelphia及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Autoimmunity After Checkpoint Blockade
招募中观察性研究
- University of Pennsylvania - Abramson Cancer Center, Philadelphia
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
招募中3 期
- Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program, Philadelphia
- Lewis Katz School of Medicine at Temple University, Philadelphia
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
招募中2/3 期
- Children's Hospital of Philadelphia - Accepting Young Adult and Juvenile Patients, Philadelphia
A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
招募中2 期
- Fox Chase Cancer Center- Temple BMT, Philadelphia
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
招募中3 期
- Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program, Philadelphia
- Lewis Katz School of Medicine at Temple University, Philadelphia
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
招募中3 期
- GSK Investigational Site, Philadelphia
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
招募中1/2 期
- Children's Hospital of Philadelphia, Philadelphia
Abatacept for the Treatment of Giant Cell Arteritis
招募中3 期
- University of Pennsylvania, Philadelphia
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
招募中3 期
- The Children's Hospital of Philadelphia, Philadelphia
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
招募中2/3 期
- Thomas Jefferson University Hospital, Philadelphia
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中观察性研究
- Children's Hospital of Philadelphia, Philadelphia
- Nemours - Alfred I. duPont Hospital for Children, Brandywine · 距离 21 英里
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
招募中1/2 期
- University of Pennsylvania, Philadelphia
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
招募中1 期
- Jefferson Einstein Hospital Philadelphia, Philadelphia
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
招募中1 期
- Temple University Hospital, Philadelphia
Central Vein Sign in Multiple Sclerosis Extension Study
招募中
- University of Pennsylvania, Philadelphia
X-linked Moesin Associated Immunodeficiency
招募中观察性研究
- Perelman School of medecine, Philadelphia
其他城市的 自身免疫性疾病试验
- Houston, TX21 项研究
- Washington, DC19 项研究
- New York City, NY19 项研究
- Durham, NC15 项研究
- Boston, MA13 项研究
- Chicago, IL12 项研究
- Los Angeles, CA12 项研究
- Dallas, TX9 项研究
- Atlanta, GA8 项研究
- Portland, OR8 项研究
- Milwaukee, WI8 项研究
- Cleveland, OH8 项研究
Philadelphia的其他研究
- 癌症（所有类型）59 项研究
- 乳腺癌56 项研究
- 非小细胞肺癌51 项研究
- 转移性癌症46 项研究
- 前列腺癌44 项研究
- 结直肠癌44 项研究
- 卵巢癌44 项研究
- 肺癌36 项研究
- 急性髓系白血病34 项研究
- 心力衰竭31 项研究
- 子宫内膜癌28 项研究
- 抑郁症26 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。